Ipsen at a glance

Innovation for

patient care

Press releases

12 April 2014

Ipsen announces a first set of results on positive phase III clinical study of Dysport® in the treatment of adults suffering from Upper…

11 April 2014

The Fondation Ipsen celebrates its 30th anniversary with a prestigious conference on the perspectives of cancer research, "Biology viewed…

YOU ARE ON IPSEN'S CORPORATE WEBSITE

The corporate website is governed by the International Federation of Pharmaceutical Manufacturers & Associations code of practice.
Certain information provided on this website may not be strictly in conformity with the French regulations on advertising.

> Close